Skip to main content
Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
1.050
-0.060 (-5.41%)
Dec 27, 2024, 10:16 AM EST - Market open

Barinthus Biotherapeutics Revenue

Barinthus Biotherapeutics had revenue of $14.97M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $14.97M, up 106.21% year-over-year. In the year 2023, Barinthus Biotherapeutics had annual revenue of $802.00K, down -98.21%.

Revenue (ttm)
$14.97M
Revenue Growth
+106.21%
P/S Ratio
2.76
Revenue / Employee
$115,146
Employees
130
Market Cap
43.45M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023802.00K-43.90M-98.21%
Dec 31, 202244.70M44.44M16,580.22%
Dec 31, 2021268.00K-4.55M-94.44%
Dec 31, 20204.82M-2.02M-29.57%
Dec 31, 20196.85M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Neuronetics 72.71M
CASI Pharmaceuticals 22.06M
iCAD, Inc. 18.94M
Omega Therapeutics 8.10M
Nutriband 2.02M
vTv Therapeutics 1.00M
Exicure 500.00K
VYNE Therapeutics 493.00K
Revenue Rankings

BRNS News

More News